Eli Lilly Hires AstraZeneca's Jan Lundberg To Replace Steve Paul As Head Of R&D
This article was originally published in The Pink Sheet Daily
Executive Summary
The move comes amid a vast R&D reorganization at Lilly which, like AstraZeneca, is laboring to speed compounds into and through development.
You may also be interested in...
R&D Swapping: AstraZeneca Lures Mackay From Pfizer To Head Global R&D
Pfizer in turn appoints Mikael Dolsten, an ex-Wyeth executive, as its worldwide R&D president.
R&D Swapping: AstraZeneca Lures Mackay From Pfizer To Head Global R&D
Pfizer in turn appoints Mikael Dolsten, an ex-Wyeth executive, as its worldwide R&D president.
AstraZeneca Reports Higher Profits, But Cuts R&D Jobs
AstraZeneca's patent expiry woes clear amid disappointing '09 results.